- 24 h
- letzte 200 News
| Zeit | Aktuelle Nachrichten | ||
|---|---|---|---|
| 09.10. | Lilly names Thomas Fuchs as its first chief AI officer | ||
| 09.10. | Sage takes another hit as Alzheimer's drug is canned | ||
| 09.10. | NICE turns down Takeda colorectal cancer drug | ||
| 09.10. | Biogen, Talkiatry team up on postpartum depression | ||
| 08.10. | Astellas places $2bn+ bet on AviadoBio dementia gene therapy | ||
| 08.10. | Setback for J&J's TAR-200 bladder cancer programme | ||
| 08.10. | AZ and Owkin partner on AI to speed up BRCA testing | ||
| 08.10. | Scholar Rock preps filings after SMA antibody clears trial | ||
| 07.10. | MicroRNA pioneers win Nobel Prize for medicine | ||
| 07.10. | AZ extends cardiovascular pipeline with $2bn CSPC deal | ||
| 07.10. | NHS England to be given a bigger role in GP data sharing | ||
| 07.10. | AZ, Avillion's Airsupra aces asthma rescue therapy trial | ||
| 07.10. | Activist investor Starboard builds $1bn Pfizer stake | ||
| 07.10. | Mendaera's $73m raise heads digital financings | ||
| 04.10. | Mounjaro and Zepbound shortages over, declares FDA | ||
| 04.10. | FDA approval give BMS an edge in NSCLC treatment | ||
| 03.10. | Gilead strikes deal to expand HIV drug access in 120 countries | ||
| 03.10. | Research shows NHS, industry partnership benefits patients | ||
| 03.10. | AI pathology accelerates with Proscia Concentriq launch | ||
| 02.10. | Revisionist history on healthcare at the VP debate | ||
| 02.10. | Blue Shield of California bypasses PBMs to slash Humira prices by 90% | ||
| 02.10. | Amgen to face investor lawsuit over $10.7bn tax liability disclosure | ||
| 02.10. | FDA issues summary of grants, promotes rare disease research | ||
| 30.09. | Chiesi Biotech Center of Excellence opens to strengthen R&D in Italy | ||
| 30.09. | SEC charges Cassava over 'misleading' Alzheimer's claims |
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und .
